Authors
Latest:
What factors affect patient reviews of urologists?"What we found is that it's very difficult to raise your review on these websites, but fairly easy to drop your review," says Jake Miller, MD.
Latest:
Treatment and Co-Management of mCRPC Patients with Aggressive DiseaseThis video segment explores treatment approaches for PSMA-positive mCRPC patients, algorithms for monitoring liver dysfunction in advanced CRPC, and exciting advancements in mCRPC treatment.
Latest:
Forward Looking NMIBC Treatment Advancements and Needs in 2024In this final episode, panelists conclude with reflections on the significant progress made in treating NMIBC over the past decade, particularly in the last 5 years. Looking ahead to 2024, experts in urology express excitement about investigational treatments (ie, cretostimogene grenadenorepvec and UGN 102), the potential for personalized medicine, emphasizing the need to understand molecular characteristics of the disease for better treatment customization. The session also highlights the importance of balancing quality of life with effective treatment strategies, and the prospect of utilizing emerging therapies early in the disease process.
Latest:
ARV-766 shows promising efficacy and tolerability in mCRPCResults presented from a phase 1/2 trial of ARV-766 demonstrated efficacy and tolerability in patients whose metastatic castration-resistant prostate cancer progressed after androgen receptor pathway inhibitor therapy.
Latest:
Money Matters: Expert on why annuities are the “Swiss Army knife” of personal financeSocial Security benefits aren’t sufficient to fund retirement for most people. And given the aging of the population and projected trust-fund shortfall, they may be less generous in the future.
Latest:
Vaginal prolapse repair and sling surgery significantly reduce UUI"The biggest message from this study is that 60% can expect resolution of UUI, simply by fixing the prolapse and placing a sling, which is not normally indicated for UUI," according to Christina M. Mezes, DO, and Catherine A. Matthews, MD.
Latest:
Pearls & Perspectives: Urology's role in GLP-1 RA treatments, with Hossein Sadeghi-Nejad, MD, and Nathalie Eid, BAThis episodes explores the evolving role of GLP-1 medications in testosterone management and their impact on male sexual health and fertility.
Latest:
Geoffrey Sklar, MD, on integrating AI in a way that augments urologic care“I think this is the future, and if we don't go down that path and we don't explore, we're not going to make it better for us and for the patients,” says Geoffrey N. Sklar, MD, FACS.
Latest:
Biomarkers in urology: Policy and legislative advances"The AACU has been discussing the evolution of state policy to ensure that biomarker testing, including PSA screening, is covered by payers," writes Ron Lanton, Esq.
Latest:
Perioperative cabozantinib shows promise in metastatic kidney cancerPerioperative treatment with cabozantinib is feasible with early signs of clinical activity in patients with intermediate- and poor-risk metastatic renal cell carcinoma.
Latest:
Roger Dmochowski, MD, on real-world persistence with vibegron for OABNearly 60% of patients taking vibegron remained on treatment at 1 year.
Latest:
Fertility preservation in patients with testicular cancer"Full discussion of the various fertility preservation options and an understanding of the fertility implications of the various treatment modalities must be understood by patients for them to make optimal decisions for their reproductive futures," write the authors.
Latest:
Race-based adjustment of eGFR: Current opinions and impact on urologic oncology“As other factors such as access to care, socioeconomic conditions, patient preference, and other unknown confounders might have played a role in the observed disparity, it is still unclear whether overestimating the postoperative eGFR of Black patients contributes to the lower use of nephron-sparing approaches in this population,” the authors write.
Latest:
Akanksha Mehta, MD, MS, highlights the residency program at Emory Urology"This year, we are starting an international rotation with a focus on global health and humanitarian work," says Akanksha Mehta, MD, MS.
Latest:
Despite overall gains, leadership and payment gaps remain for women in medicine"The good news is that women have been entering medicine in increasing numbers for more than three decades. The not-so-good news is that women are still underrepresented and underutilized in positions of power," writes Deborah M. Shlian, MD, MBA.
Latest:
EP. 4B: Educating Patients on Their Treatment Options for LG UTUCIn this companion article, Armine K. Smith, MD, reflects on the role of kidney-sparing approaches for LG UTUC and emphasizes the importance of patient-provider communication when making treatment decisions.
Latest:
Expert insight on ransomware: Is your practice prepared?Ransomware has never been a more serious threat for health care organizations, even small medical practices.
Latest:
Closing Thoughts on Urology Practice Management and Treatment of Advanced Prostate CancerClosing out their discussion on how treatment and management of advanced prostate cancer affects their clinical practice, expert urologists consider how the therapeutic landscape continues to evolve and look toward future evolutions in care.
Latest:
How APPs can be involved with genitourinary cancer careA nurse practitioner discusses how she supports multiple providers in a large academic practice.
Latest:
Identifying unique therapeutic targets for chromophobe kidney cancer“What we hope overall is that this is a biological study that might inform therapeutic development for this disease,” says David A. Braun, MD, PhD.
Latest:
Moving transperineal prostate biopsy into the clinicLearning curve for technique is short, but capital expenditures are required.
Latest:
Case 1: A 79-Year-Old Man With Non–Muscle-Invasive Bladder CancerPanelists discuss how they approach a typical bladder cancer case of a 79-year-old man with hematuria, including initial diagnostic procedures, the importance of proper tumor measurement during resection, BCG therapy protocols, and management options for BCG-unresponsive disease with a focus on nadofaragene firadenovec (Adstiladrin).
Latest:
App shows promise in managing lower urinary tract symptomsChristian Gratzke, MD, explains why an app shows promise for patients with lower urinary tract symptoms.
Latest:
Expert Opinion: We cannot continue to ignore the problem of physician mental distress"We need health systems, state medical boards and physician employment settings to commit to prioritizing physician wellbeing and provide the reassurances and resources that encourage physicians in need to seek help," writes Russell Libby, MD.
Latest:
Malpractice Consult: How likely are you to face a medical malpractice lawsuit?"Although there is a good chance that you will face allegations of medical negligence at some point in your career, it is unlikely that you will ever be found liable by a jury," writes Victoria L. Neikam, Esq.
Latest:
Future Directions for Imaging and Biopsy in Prostate CancerThe panel offers key takeaways on the evolving landscape for imaging and biopsy in prostate cancer, highlighting the role for fusion-guided biopsy in the diagnosis and management of prostate cancer.
Latest:
Leilei Xia, MD, on the role of extended lymph node dissection post-S1011 trial"That gave us the idea that the diagnostic benefit of extended lymph node detection was pretty minimal," says Leilei Xia, MD.
Latest:
US Chamber of Commerce asks for delay on non-compete ruleThe request comes amid growing concerns about the rule’s implications for businesses and employees nationwide.
Latest:
Novel dual agents for advanced prostate cancerA recap of presentations from AUA 2021 highlighting next steps using novel therapies as combination approaches to treat advanced prostate cancer.
